Rockland Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-143,106
Closed -$668K 161
2016
Q1
$668K Hold
143,106
0.12% 93
2015
Q4
$723K Hold
143,106
0.13% 89
2015
Q3
$504K Hold
143,106
0.1% 98
2015
Q2
$1.43M Hold
143,106
0.28% 60
2015
Q1
$1.82M Buy
+143,106
New +$1.82M 0.39% 56